Quintiles Named to Fortune Magazine's 2016 List of “World’s Most Admired Companies”
Ranked First in Industry Category and Four Key Attributes
RESEARCH TRIANGLE PARK, N.C.--(Business Wire/Korea Newswire) February 23, 2016 -- Quintiles, the world’s largest biopharmaceutical services company, has been named to Fortune magazine’s “World’s Most Admired Companies” list for 2016, the second year in a row for this distinction.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160222005202/en/
Quintiles is ranked first overall in Fortune’s Healthcare: Pharmacy and Other Services industry category, up from number three in 2015.
Also within its industry category, Quintiles was ranked first or second across all nine “key attributes” which Fortune survey respondents use in evaluating nominated companies. The company was ranked first in the categories of:
· Quality of Products / Services
· Global Competitiveness
· Long-term Investment
· Social Responsibility
Fortune‘s “World’s Most Admired Companies” list is the definitive report card on corporate reputations. Since 1997, Fortune has identified, selected and ranked the World’s Most Admired Companies (http://goo.gl/fhDDwa), uncovering the business practices that make these companies highly regarded among their peers.
“It was an honor and a milestone for Quintiles to be named to Fortune’s list of most admired companies for the first time in 2015,” said Quintiles Chief Executive Officer Tom Pike. “A second consecutive year on the list is a reflection of the caliber and dedication of our 36,000 employees around the world as they work to improve our customers’ probability of success.
“Equally important, Quintiles’ inclusion on the Fortune list is further motivation for us to commit to leadership and growth in line with our values. We never lose sight of our role in improving healthcare and the need to live up to our recognized reputation.”
Most Admired Methodology
The survey employed by Fortune to designate its “World’s Most Admired Companies” list assesses nine reputation drivers considered to be crucial to a company’s global success including financial soundness, long-term investment value, people management, social responsibility, use of assets, quality of management, quality of products/services, innovation and global competitiveness.
These attributes were developed prior to the inception of the Most Admired Companies rankings through a series of interviews with executives and industry analysts to determine the qualities that make a company worthy of admiration.
Raters are asked to evaluate each eligible company on attributes by assigning a score from zero (‘Poor’) to ten (‘Excellent’). For the purposes of the industry rankings, a company’s overall score is determined through a simple average of the individual attribute scores. Companies who rank in the top half of their industry are defined as “most admired” within their industry.
Quintiles (NYSE: Q) helps biopharma and other healthcare companies improve their probability of success by connecting insights from our deep scientific, therapeutic and analytics expertise with superior delivery for better outcomes. From advisory through operations, Quintiles is the world’s largest provider of product development and integrated healthcare services, including commercial and observational solutions. Conducting operations in approximately 100 countries, Quintiles is a member of the Fortune 500 and has been named to Fortune’s list of the “World’s Most Admired Companies.” To learn more, visit www.quintiles.com.
Click here (http://goo.gl/XXiXBC) to subscribe to Mobile Alerts for Quintiles.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160222005202/en/